We are a clinical-stage biotechnology company focused on restoring function by developing therapeutics that activate a person’s innate regenerative potential.
Frequency is leading a new category in regenerative medicine designed to activate a person’s innate regenerative potential, within the body, to repair tissue and restore function.
Developing small-molecule treatments to reverse the debilitating impact of degenerative diseases
Hearing loss caused by damage to the sensory cells of the ear impacts hundreds of millions of people globally. Currently there are no FDA-approved treatments to address the underlying condition.
Chairman
Co-founder, President and CEO
Co-founder and CEO and Chairman of Sepracor (retired)
Independent Board Member
Managing Partner, Taiwania Capital Management
Institute Professor, Massachusetts Institute of Technology
Executive Chairman and Founder, Alexandria Real Estate Equities, Inc.
